Enantiospecific, selective cyclooxygenase-2 inhibitors

Bioorganic & Medicinal Chemistry Letters
2002.0

Abstract

Cyclooxygenase inhibition studies with novel indomethacin alkanolamides demonstrate the potential for dramatic differences in inhibitor properties conferred by subtle structural modifications. The transformation of non-selective alpha-(S)-substituted indomethacin ethanolamides to potent, COX-2 selective inhibitors by simple stereocenter inversion highlights this property.

Knowledge Graph

Similar Paper

Enantiospecific, selective cyclooxygenase-2 inhibitors
Bioorganic & Medicinal Chemistry Letters 2002.0
Structural Basis of Enantioselective Inhibition of Cyclooxygenase-1 by S-α-Substituted Indomethacin Ethanolamides
Journal of Biological Chemistry 2007.0
Ester and Amide Derivatives of the Nonsteroidal Antiinflammatory Drug, Indomethacin, as Selective Cyclooxygenase-2 Inhibitors
Journal of Medicinal Chemistry 2000.0
Synthesis and biological evaluation of both enantiomers of L-761,000 as inhibitors of cyclooxygenase 1 and 2
Bioorganic & Medicinal Chemistry Letters 1996.0
From indomethacin to a selective COX-2 inhibitor: Development of indolalkanoic acids as potent and selective cyclooxygenase-2 inhibitors
Bioorganic & Medicinal Chemistry Letters 1996.0
A new class of acyclic 2-alkyl-1,2-diaryl (E)-olefins as selective cyclooxygenase-2 (COX-2) inhibitors
Bioorganic & Medicinal Chemistry Letters 2004.0
The 2′-Trifluoromethyl Analogue of Indomethacin Is a Potent and Selective COX-2 Inhibitor
ACS Medicinal Chemistry Letters 2013.0
Thiazole analogues of the NSAID indomethacin as selective COX-2 Inhibitors
Bioorganic & Medicinal Chemistry Letters 2001.0
Synthesis and evaluation of carbaborane derivatives of indomethacin as cyclooxygenase inhibitors
Bioorganic & Medicinal Chemistry 2011.0
Structural modification of indomethacin toward selective inhibition of COX-2 with a significant increase in van der Waals contributions
Bioorganic & Medicinal Chemistry 2019.0